Neuphoria Therapeutics Inc. (NEUP) stock
NEUPNasdaqPharmaceutical PreparationsFiscal year ends June 30
$2.55−0.03 (-1.16%)
Close on Nov 13, 2026Market cap $76.66KP/E –Yield –
Neuphoria Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Neuphoria Therapeutics's enterprise value was -$19.78M on Nov 11, 2026, against -$13.59M a year earlier. Over the last 5 years it ranged from -$23.14M to $302.11K, with a median of -$12.67M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$19.78M | – |
| 2025 | Dec 31, 2025 | -$13.60M | – |
| 2024 | Dec 31, 2024 | -$8.05M | – |
| 2023 | Dec 29, 2023 | -$12.11M | – |
| 2022 | Dec 30, 2022 | -$23.01M | -7716.8% |
| 2021 | Dec 31, 2021 | $302.11K | – |
See a number that looks wrong?